Sotelo Eddy, Fraiz Nuria, Yáñez Matilde, Terrades Vicente, Laguna Reyes, Cano Ernesto, Raviña Enrique
Laboratorio de Química Farmacéutica, Departamento de Química Orgánica, Facultad de Farmacia, Universidad de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Bioorg Med Chem. 2002 Sep;10(9):2873-82. doi: 10.1016/s0968-0896(02)00146-3.
A series of 6-phenyl-3(2H)-pyridazinones with a diverse range of substituents in the 5-position have been prepared and evaluated in the search for new antiplatelet agents. A significant dependence of the substituent on the inhibitory effect has been observed. The pharmacological study of these compounds confirms that modification of the chemical group at position 5 of the 6-phenyl-3(2H)-pyridazinone system influences both variations in the antiplatelet activity and the mechanism of action.